Medicines—Aims and Scope Updates
Hiroshi Sakagami
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsPharmaceutical studies and practices · Pharmacovigilance and Adverse Drug Reactions
The journal Medicines (ISSN 2305-6320) was launched in 2014. Since then, it has had numerous interesting publications covering all areas of medical disciplines and subspecialties. Following the latest feedback from Scopus, we are updating our scope so it is more in alignment with the papers published in our journal.
We aim to better serve the readers and authors by providing more space for publication in the fields of therapeutic agents and advanced drug studies, but not in those of diet and nutrition, biological and stem-cell therapy, radiation and other nonsurgical therapeutic strategies, palliative care and physical therapy, and multimodal therapy.
Following a thorough review of the published papers and developments in the research fields that we address, we concluded that the subjects that fall within the scope of this journal are perhaps too extensive and could benefit from some fine adjustments. More details are presented in Table 1.
For more information about journal Medicines, please visit the following link: https://www.mdpi.com/journal/medicines/.